Emory University: Pancreatic Neoplasms trials
The registry lists 12 Pancreatic Neoplasms studies with Emory University as lead sponsor. 1 are open to participants now and 6 have results posted.
Phase 1 7Phase 2 6No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant ChemotherapyRecruitingNCT06595160
- Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic CancerCompletedNCT04524702Phase 2Results posted
- Siltuximab and Spartalizumab in Patients With Metastatic Pancreatic CancerCompletedNCT04191421Phase 1/2Results posted
- Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic CancerCompletedNCT03910387Phase 2Results posted
- Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal CancerCompletedNCT03095781Phase 1Results posted
- Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney CancerTerminatedNCT02273752Phase 2Results posted
- Gemcitabine/Cisplatin for Resected Pancreas Cancer: Establishing the Role of ERCC1 in Treatment DecisionTerminatedNCT01188109Phase 2Results posted
- VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal CancerCompletedNCT03373188Phase 1
- TAS102 in Combination With NAL-IRI in Advanced GI CancersActive, not recruitingNCT03368963Phase 1/2
- Palbociclib With Cisplatin or Carboplatin in Advanced Solid TumorsCompletedNCT02897375Phase 1
- Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic CancerCompletedNCT01446458Phase 1
- Study of Gemcitabine With TheraSphere® (Yttrium-90)in Patients With Hepatic Tumors of Pancreatobiliary OriginTerminatedNCT01434459Phase 1